Randomized controlled trials of autologous hematopoietic stem cell transplantation for autoimmune diseases: the evolution from myeloablative to lymphoablative transplant regimens.
Burt
Richard K
RK
Northwestern University Feinberg School of Medicine, Chicago, Illinois 60011, USA. rburt@northwestern.edu
Marmont
Alberto
A
Oyama
Yu
Y
Slavin
Shimon
S
Arnold
Renate
R
Hiepe
Falk
F
Fassas
Athanasios
A
Snowden
John
J
Schuening
Friedrich
F
Myint
Han
H
Patel
Dhavalkumar D
DD
Collier
David
D
Heslop
Helen
H
Krance
Robert
R
Statkute
Laisvyde
L
Verda
Larissa
L
Traynor
Ann
A
Kozak
Tomas
T
Hintzen
Rogier Q
RQ
Rose
John W
JW
Voltarelli
Julio
J
Loh
Yvonne
Y
Territo
Mary
M
Cohen
Bruce A
BA
Craig
Robert M
RM
Varga
John
J
Barr
Walter G
WG
D001327:Autoimmune Diseases / Q000401:mortality / Q000628:therapy*; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008214:Lymphocytes / Q000187:drug effects; D019653:Myeloablative Agonists / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D015996:Survival Rate; D019172:Transplantation Conditioning / Q000379:methods*; D014182:Transplantation, Autologous
D007166:Immunosuppressive Agents; D019653:Myeloablative Agonists